AI-generated summary
This paper proposes a hypothetical mechanism for how low-level laser treatment may act, centered on protein-to-protein interactions, SUMO modification and ion channel modulation, with mitochondria as the main laser absorption target. The authors report that the hypothesis is supported by recent research but present it as a model rather than a tested finding. The abstract does not report new experimental data on patients.
- Wavelengths
- 450, 910 nm
- Limits stated in the abstract
- The abstract presents a hypothesis and proposed model rather than reporting new experimental or clinical results, and it does not state the strength of the supporting evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 450-910 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Inflammation, Mitochondria, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.